Vetdox AQ Pro is a dual-action veterinary tablet containing Atovaquone (250mg) and Proguanil Hydrochloride (100mg), designed for the effective treatment of canine babesiosis caused by Babesia gibsoni. It is often used in combination with azithromycin and may also support treatment of cytauxzoonosis and other protozoal infections when standard therapies are ineffective.
Babesiosis: Atovaquone often combined with azithromycin is used to treat Babesia gibsoni in dogs.
Cytauxzoonosis: Some reports suggest its use in treating Cytauxzoon felis in cats.
Other Protozoal Infections: May be used in cases where standard therapies are ineffective.
Atovaquone: 13.3–15 mg/kg every 8 hours for 8–10 days
Proguanil: 5 mg/kg every 8 hours for 8–10 days
Vetdox AQ Pro comes in just one variation a 10-tablet pack because it is specifically designed for short, targeted treatments like babesiosis and protozoal infections, which typically require an 8–10 day course. Having a single, fixed-dose pack ensures accurate dosing, better compliance, and treatment completion without confusion. This makes it convenient for both veterinarians and pet owners, ensuring the best results without wastage or dosing errors.
The combination of atovaquone and proguanil hydrochloride exhibits a synergistic effect against Babesia gibsoni, leading to more effective parasite clearance than either drug alone. This synergy disrupts the parasite's mitochondrial electron transport chain, impairing its energy production and leading to its death. Studies have demonstrated that this combination therapy significantly reduces parasitemia levels and improves clinical outcomes in infected dogs .
Babesia gibsoni infections can be challenging to treat due to the emergence of drug-resistant strains. Vetdox AQ Pro's formulation has shown efficacy in cases where standard therapies have failed, including infections resistant to other antiprotozoal medications. Clinical studies have reported that the atovaquone-proguanil combination, especially when used alongside azithromycin, can lead to significant reductions in parasitemia and clinical improvement in dogs with both acute and chronic stages of infection .
Vetdox AQ Pro has been shown to have a favorable safety profile in dogs. In clinical evaluations, side effects were minimal and self-limiting, with some dogs experiencing mild gastrointestinal symptoms such as vomiting. Importantly, the treatment did not result in significant adverse effects on liver enzymes or other critical health parameters, making it a well-tolerated option for managing Babesia gibsoni infections .
Q
What is VETDOX AQ PRO?
A
VETDOX AQ PRO is a dual-action veterinary tablet combining Atovaquone and Proguanil, specially formulated to treat relapsing canine babesiosis caused by Babesia gibsoni.
Q
How does VETDOX AQ PRO help my pet?
A
VETDOX AQ PRO targets protozoal infections, improving recovery from babesiosis by effectively clearing parasites and boosting your pet’s health.
Q
When should I use VETDOX AQ PRO for my dog?
A
Use VETDOX AQ PRO when your veterinarian diagnoses your pet with babesiosis, especially if the infection is relapsing or resistant to standard treatments.
